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Hepatitis B
Kayla Rodgers, RN-BSN
Otterbein University, Westerville, Ohio
Introduction
When one chooses a career in
healthcare, they know that there is a
chance of exposure to harmful diseases
and germs. To better reduce the chances
of contracting some of these diseases,
vaccinations have become required for
those with the potential to be exposed;
one of these diseases is hepatitis B (HBV).
While the number of acute hepatitis B
infections has been decreasing, in 2016
the Centers for Disease Control (CDC)
reported that there was still 1 case per
100,000 people (2019). According to the
CDC, healthcare workers are some of the
most at-risk individuals to contract this
disease, as the virus is transmitted by
“blood and blood containing body fluids”
(2019). This paper will look at the
disease process, pathophysiology, and
implications for nurses of hepatitis B
and discuss actions that can reduce the
risk of transmission to healthcare
workers, as well as their patients.

Case Presentation
A 23-year-old male comes to the
emergency department with complaints
of abdominal pain, decreased appetite,
as well as dark urine for approximately
6 weeks. The nurse notes on exam that
the patients' skin and sclera have a
yellow discoloration, as well as track
marks noted to arms. When
questioned, the patient states that he is
an intravenous drug user, and that he is
unsure if the needles he has been using
have been clean. He is also unsure if he
has been vaccinated for hepatitis in the
past. Upon exam, nurse notes that
the patient has tenderness on palpation
to right upper quad and believes that
she able to palpate the liver. Patient
develops nausea and vomiting while in
emergency department. Also, Patient
had a bowel movement that was
discolored which he reports has been
going on for approximately 2 weeks.
Heart sounds are within normal limits,
no murmur or other irregularities
noted. Lung sounds are clear in all
fields. No swelling noted to extremities.
Skin is yellow, warm, and clammy. Vital
signs are as follows: heart rate is 103,
respirations are 18, blood pressure is
123/83, oxygenation is 98 percent, and
temperature is 102.1. The nurse is
suspicious of Hepatitis B. The nurse
must now produce a plan of care for the
patient and explore possible treatment
and look at prevention methods for
recurring infections.

Signs and Symptoms
of Hepatitis B
According to the Centers for Disease
Control, the signs and symptoms of
Hepatitis B are:
•
Fever
•
Fatigue
•
Joint pain
•
Nausea
•
Vomiting
•
Loss of appetite
•
Abdominal Pain
•
Dark urine
•
Clay colored Stools
•
Jaundice
They also identified the following as atrisk populations:
•
Intravenous drug users
•
HIV positive patients
•
Men who have sex with men
•
Person requiring
immunosuppressive therapy
•
Blood and tissue donors
•
Infants born to mothers who are
hepatitis B positive
•
Persons with end stage renal
disease
•
Foreign born persons
As well, those who work in healthcare
may be at increased risk of contraction
due to exposure to body fluids from
patients who may be Hepatitis B
positive. Many healthcare organizations
require that employees be
vaccinated for Hepatitis B or have
records of previous vaccination. As
well, titers to confirm immunity may be
required if vaccination has not been
recent.

Underlying
Pathophysiology
According to Branstetter-Hall &
Felicilda-Reynaldo, hepatitis B is a virus
that has its own deoxyribonucleic acid
(DNA) sequence that infects the normal
cells of the body, mainly the liver, and
replicates the infected cells growing the
virus. Many of these cells move to the liver
where newly infected cells are made and
can adapt. This change from producing
normal liver cells to making these infected
cells damages the liver. When these cells
form, they also create several different
antigens and antibodies that can be
detected in the blood of those who are
infected. The antibodies that are formed
after someone is infected include IgM and
several different varieties of IgG anti-HB.
As previously stated, titers can be
drawn to check levels of immunity from
HBV and these titers look at the antibody
IgG Anti-HB to see if levels are high enough
to indicate immunity. There are also four
stages of HBV, which include the immune
tolerant phase, immune active phase,
inactive carrier phase, as well as the
reactivation phase. Many times, patients do
not know that they have the virus and do
not seek care until they have reached the
immune active phase. In this phase, the
immune system realizes that it has been
compromised and starts to combat the
infection at the expense of the liver. This is
the phase that can cause the most serious
complications, such as cancer and cirrhosis
( 2017).

Implications for
Nursing Care

http://www.nfid.org/hepatitis-b-toolkit

Significance of underlying pathophysiology
As described before, HBV attacks the healthy cells of the liver causing damage
that can be short or long term. To help combat these effects, there has been
research into the use of antivirals for those diagnosed with HBV. The thought
behind this process is that the use of antivirals could stop or limit the spread of
the infection. These medications and ideas on how and who they may work for is
better described in the works of Branstetter-Hall & Felicilda-Reynaldo. They
discuss the various different types antiviral drugs used to treat chronic
HBV. These medications are classified as nucleoside reverse transcriptase
inhibitors (NRTIs) or nonnucleoside reverse transcriptase inhibitors (NNRTIs)
(2017).
There is also a series of vaccinations that may be given to those a risk. These
vaccines work the same as many other vaccines in which the body is introduced
to small amounts of the antibodies from a virus, so that if the body is exposed to
these antibodies in the future, they have the ability to recognize them and start
the process of fighting off the infection before it can spread. However, as
evidenced by the works of Cloherty, Holzmayer, Kuhns, and McNamara, even
with these vaccines there are chances of breakthrough infection. In their
work, they studied two samples that were found to be breakthrough infections of
HBV. In these breakthrough samples, there is a differing sequence of events
described by the authors as “Vaccine breakthrough infections differ from typical
acute HBV infection where the order of appearance of viral markers in the
peripheral blood follows a consistent pattern with hepatitis B viral DNA (HBV
DNA) followed by HBsAg, hepatitis B e antigen (HBeAg), and antibody to hepatitis
B core antigen (anti-HBc). Resolution of infection in typical acute infection is
marked by loss of serum HBsAg and HBV DNA and the appearance of anti-HBs. In
contrast, during breakthrough infections, HBV DNA becomes detectable in
vaccinated individuals who have protective levels of anti-HBs” (2019). In the
works by Avileli, Basireddy, Beldono, & Gundela, they found that increased age,
smoking, and increase body mass index can all lead to decreased effectiveness of
the vaccines for HBV (2018).

In terms of caring for patients, there
needs to be education on HBV available
to patients and families, so that there is
not a spread of the virus in the
household or among sexual partners.
The nurse would also want to make
sure that the patient is aware that they
will need to follow up with a specialist
to monitor liver enzymes, as well as
hepatitis panels. In terms of
prevention, nurses need to educate all
patients on the need to have the vaccine
series and to keep up to date on all
shots. Nurses would also need to
educate on precautions for those
diagnosed with HBV on liver protection
protocols, such as limited use alcoho,l as
well as limited use of Tylenol and other
medications that can cause damage to
the already injured liver.
One would also want to educate the
patient on what type of medications
they will be going home with. According
to the Mayo Clinic website, these can
include medications such as the
antivirals that were discussed prior and
the over the counter options that they
may utilize. Depending on the acuity of
the infection, the recommendation may
be to just rest, increase fluids, and make
sure that the patient is eating a healthy
nutritious diet (2019).
As nurses caring for those who have
been diagnosed with HBV, we have to
take extra precautions. These include
donning personal protective equipment
when there is a possibility of being
exposed to bodily fluids of those
patients who may be infected. Another
precaution to consider is to stay up to
date on shots, as well as making sure
that titers are drawn to verify that there
has not been a breakthrough infection.
As well, in the rare case that a
healthcare worker is infected with
HBV, they will need to follow similar
precautions as patients. According to
Enfield, Lewis, & Sifri, they will need to
use standard precautions when coming
in contact with patients. They also state
that there is no governing body of
healthcare that prohibits the practice of
workers who are HBV positive (2015).
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Conclusion
In conclusion, due to the disease
process, there are many different
aspects that need to be addressed for
the patient. The patient in the scenario
would need to have labs and CT scans
to rule out other abdominal issues or
differential diagnosis. After a hepatitis
panel is ran, and if it comes back
positive, there will need to be a decision
whether this episode is acute or
chronic, and then from there the plan of
care can be developed. As stated by
Abara, Harris, McMahon, Qaseem,&
Schillie, the patient will need to be set
up with not just counseling for the HBV,
but also possible rehab for the
intravenous drug use if the patient is
wanting these services (2017). If the
patient is not interested in possible
rehab, they will need to be educated on
the use of clean needles and reducing
the spread of the disease. The patient
will need to discuss the use of antivirals
and the compliance with them. He will
need to be educated that because of the
HBV, he is at increased risk for other
liver related issues, such as cirrhosis
and cancer. He will need to follow up
with a specialist to monitor his liver
enzymes in the future, as well as make
sure that the hepatitis does not recur.
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